patent for semaglutide Semaglutide's expires today. What does it mean patients, pharma players and Novo Nordisk? Indian pharma companies launch low-cost
Description
Although Ozempic and Wegovy both contain the active ingredient Semaglutide, they are intended for different purposes and so have different dosages to reflect this
Stopping GLP-1 therapy requires a thoughtful plan
2 ,
Educational, not medical advice
The case for a Canadian GLP-1 programme and a model for other countries
